Skip to main content
. 2015 Nov 15;8(11):21715–21723.

Figure 5.

Figure 5

Myricitrin suppresses PDGFRβ, Akt and Erk1/2 signaling pathways activated by PDGF-BB in VSMCs. A. The proteins PDGFRβ, Akt, Erk1/2, p-Akt and p-Erk1/2 were determined using western blotting with corresponding antibodies. β-actin was used as an internal control. B-D. Data are expressed as mean ± SD; *P<0.05 compared to control group. #P<0.05 compared to PDGF-BB treatment group.